Fortrea Holdings (FTRE) Total Debt (2023 - 2026)
Fortrea Holdings' (FTRE) quarterly Total Debt came in at $1.1 billion in Q2 2026, down 10.33% on a YoY basis from $1.2 billion in Q2 2025, and little changed quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Total Debt (2023 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Total Debt for 4 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt fell 10.33% year-over-year to $1.1 billion; the trailing twelve-month figure through Jun 2026 stood at $1.1 billion (down 10.33% YoY), and the FY2025 full-year result was $1.1 billion, down 6.38% from the prior year.
- Total Debt held at $1.1 billion in Q2 2026 per FTRE's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Total Debt topped out at $1.6 billion in Q1 2024 and bottomed at $1.1 billion in Q4 2025.
- Historically, Total Debt has averaged $1.3 billion across 4 years, with a median of $1.1 billion in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Debt declined 29.98% in 2024, then grew 4.62% in 2025.
- Over 4 years, Total Debt stood at $1.6 billion in 2023, then retreated by 29.37% to $1.1 billion in 2024, then declined by 6.38% to $1.1 billion in 2025, then increased by 0.14% to $1.1 billion in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 16.00 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 2.62 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 3.39 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 1.05 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 553.13 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Bn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | 1.12 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Mar 31, 2024 | 1.61 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.60 Bn |
| Jun 30, 2023 | 1.61 Bn |